Newsletters

12.18.17

Part 1: Megatrends Reinventing How Patients Think

In early 2017, California Assembly member Jim Wood introduced Bill AB-265, banning the use of copay coupons in California when a generic equivalent drug covered by an individual’s health plan exists.


11.21.17

Fraud and Abuse 2017: Understanding Trends and Avoiding Actions

Under the Trump administration, healthcare fraud will remain a key focus.


10.24.17

A New Look at Digital Health Business Models

Few observers doubt that machine learning, voice assistants and technologies we haven’t even heard of yet will supplant our traditional “brick-and-mortar” health system.


08.23.17

By Antitrust Standards, When Is a Firm Really Failing?

The “failing firm” defense as a justification for permitting a merger that may otherwise lessen competition gets considerable play in healthcare transactions.


07.24.17

Contracting With Technology Vendors: Obligations and Compliance Strategies

Covered entities’ obligations when selecting and contracting with technology vendors require four key steps: evaluate, document, contract and monitor.


06.22.17

HIPAA and Emerging Technologies

Cybersecurity is a high priority across the Trump administration. In April, the Department of Health and Human Services (HHS) announced that it will establish a cyberthreat nerve center, modeled after Homeland Security’s National Cybersecurity and Communications Integration Center, to assess ...


05.24.17

Mapping the Healthcare M&A Landscape Under the New Administration

Healthcare M&A deal volume has been robust over the past five years and shows few signs of slowing down. Activity peaked in 2015—the year of the megadeal, particularly in the managed care and pharmaceutical arenas—with almost 1,100 deals approaching $100 billion in aggregate value.


12.19.16

Balancing Gene Therapy’s Promise and Price

Gene therapy is the therapeutic delivery of polymers into a patient’s cells for the purpose of treating a disease. Polymers interfere with gene expression or correct mutations.


09.22.16

Digital Health Update

Investment into the digital health market topped $4.5 billion in 2015, and we are seeing an acceleration of investment in 2016.


08.24.16

Section 1332 Waivers: Will We See More State Innovation?

Stakeholders across the country are focused on effectively implementing the Affordable Care Act (ACA) and making incremental—not radical—changes to it.